Resono Ophthalmic Srl

Resono Ophthalmic Srl Resono Ophthalmic is an innovative Italian SME founded in 2014 to develop and sell cutting-edge therapeutic devices for Ophthalmology.

Resono Ophthalmic is an Italian company developing therapeutical devices for Ophthalmology based on QMR®, a patented technology that stimulates the natural regeneration of cells. The key feature of our devices is the Quantum Molecular Resonance (QMR®) treatment. It is a patented technology that stimulates the natural regeneration of cells and tissue by delivering low-power, high-frequency electrical fields. We first applied this technique to treat Dry Eye Disease (DED) with Rexon-Eye®, a patented CE-marked medical device. Clinical trials in Italy and abroad have provided scientific evidence that Rexon-Eye® is a safe, effective, and long-term treatment option for all types of DED. The benefits of QMR® in stimulating cell and tissue regeneration are currently under investigation also for its possible application in other eye diseases. For more information about technical and clinical details, please visit our website.

*QMR® is a registered trademark by Telea Electronic Engineering.

Resono team would like to extend our warmest holiday wishes to all of you.May this festive season bring you rest, joy, a...
23/12/2025

Resono team would like to extend our warmest holiday wishes to all of you.
May this festive season bring you rest, joy, and renewed energy.

We look forward to coming together in the new, inspiring, and promising year ahead, filled with exciting milestones and continued innovation in eye care

  - powerful benefits for gamers Dr. Andres Benatti, Cornea and refractive surgeon, has developed a protocol with Rexon-...
04/12/2025

- powerful benefits for gamers
 
Dr. Andres Benatti, Cornea and refractive surgeon, has developed a protocol with Rexon-Eye to treat a specific and particular category affected most of the time by Dry Eye: Gamers and Content Creators.

This new generation of professionals spends long hours in front of screens, whether studying or working. Over time, their visual performance and productivity can decline due to alterations in the ocular surface.
With Rexon-Eye and QMR technology, the tear film is optimized and visual comfort is improved.
 
A special thank you to our esteemed Key Opionion Leader for sharing his valuable clinical experience
 
Discover more about the protocol: https://rexoneye.com/

12/11/2025

The treatment of Neuropathic Corneal Pain lies in regeneration

With Professor Yu-Chi Liu, corneal specialist and clinician scientist at the Singapore National Eye Centre and Associate Professor at Duke–National University of Singapore, a clinical study is currently underway on the treatment of Neuropathic Corneal Pain with Rexon-Eye and Technology.
This ongoing study has already shown very promising results, demonstrating the efficacy of QMR in regenerating the corneal nerves.

A heartfelt thank you to Professor Yu-Chi Liu and her institution for their invaluable collaboration.

Watch the full interview 👉 https://lnkd.in/djXkMcts

Have you ever experienced a cozy treatment for Dry Eye?It’s possible with Rexon-EyeProviding anti-inflammatory and regen...
29/10/2025

Have you ever experienced a cozy treatment for Dry Eye?
It’s possible with Rexon-Eye

Providing anti-inflammatory and regenerative effects on the ocular surface thanks to QMR technology, Rexon-Eye offers also a truly relaxing and non-invasive experience, making a wellness area possible.
It not only alleviates dry eye symptoms for long time by acting on the cause of the disease and regeneration of the cell, but also reduces the stress and discomfort associated with the condition — turning therapy into a moment of wellness and comfort.

Many clinics are now embracing this Wellness Solution approach.

Are you experiencing or managing Dry Eye?
Contact us to learn more 👉🏼https://rexoneye.com/contact-us/

🇬🇧 Rexon-Eye journey in UKLast week our official distributor for UK and Ireland Hanson Medical showcased and demostrated...
25/09/2025

🇬🇧 Rexon-Eye journey in UK

Last week our official distributor for UK and Ireland Hanson Medical showcased and demostrated, with Charley Evans and Pete Downing FBDO, technology and Rexon-Eye at the Eyecare Birmingham education event.

We are proud of their energy and deeply grateful for their commitment in raising awareness about QMR, an innovative and comprehensive technology for the ocular surface treatment.

Want more information? 👉 https://www.hansoninstruments.co.uk/

The European Society of Cataract and Refractive Surgeons (ESCRS) 2025 in Copenhagen has come to a close – but it has wri...
19/09/2025

The European Society of Cataract and Refractive Surgeons (ESCRS) 2025 in Copenhagen has come to a close – but it has written a new remarkable chapter in the history of Rexon-Eye and technology.

Taking part to the Innovation Final Day first, marks QMR technology as one of the most advanced and innovative solutions of the future in eye disease care.
At ESCRS, we shared not just a technology, but a vision and a common goal: redefining the future of eye care through the real regeneration while ensuring the best patient experience — the wellness solution.

A heartful thank you for bringing this vision with their clinical success stories to Prof. Luigi Donato, Prof. Yu-Chi Liu, Dr. Giovanni Roberto Tedesco , Dr. Luca Vigo MD .luca and Dr. Andrés Benatti .benatti

And a special thank you to all our distributors for fostering connections and building networks — values of our company.

“The key of the medicine is the regeneration”

Get more information 👉 https://rexoneye.com

The European Society of Cataract and Refractive Surgeons   2025 in Copenhagen has come to a close – but it has written a...
19/09/2025

The European Society of Cataract and Refractive Surgeons 2025 in Copenhagen has come to a close – but it has written a new remarkable chapter in the history of Rexon-Eye and technology.

Taking part to the Innovation Final Day first, marks QMR technology as one of the most advanced and innovative solutions of the future in eye disease care.
At ESCRS, we shared not just a technology, but a vision and a common goal: redefining the future of eye care through the real regeneration while ensuring the best patient experience — the wellness solution.

A heartful thank you for bringing this vision with their clinical success stories to Prof. Luigi Donato, Prof. Yu-Chi Liu, Dr. Giovanni Roberto Tedesco, Dr. Luca Vigo MD and Dr. Andrés Benatti.

And a special thank you to all our distributors for fostering connections and building networks — values of our company.

"The key of the medicine is the regeneration"

Get more information 👉 https://rexoneye.com

The European Society of Retina Specialists (EURETINA) 2025 in Paris is now part of our history, marked by outstanding re...
09/09/2025

The European Society of Retina Specialists (EURETINA) 2025 in Paris is now part of our history, marked by outstanding results.

A special thank you to Dr. Luigi Donato for presenting the first in-vitro study with hashtag Technology applied to Retinal Pigment Epithelium (RPE).
A promising step forward in tackling one of the most challenging areas in retinal disease.

Read the full article here: https://lnkd.in/dudqgGsE

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090Join us to discover the wide-ranging applications and achievem...
03/09/2025

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090

Join us to discover the wide-ranging applications and achievements of Rexon-Eye and Technology in real-world clinical practice.

Leading experts Dr. Giovanni Roberto Tedesco , Dr. Luca Vigo MD .luca , and Dr. Andrés Benatti .benatti will present their insights and clinical experience in the management of Dry Eye.

Where:📍 Booth C2.090 at 43rd The European Society of Cataract and Refractive Surgeons (ESCRS)

Check out our program and save the dates!

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090Join us to discover the wide-ranging applications and achievem...
02/09/2025

ESCRS 2025, Copenhagen - Rexon-Eye Speeches – Booth C2.090

Join us to discover the wide-ranging applications and achievements of Rexon-Eye and hashtag Technology in real-world clinical practice.

Leading experts Dr. Giovanni Roberto Tedesco, Dr. Luca Vigo, and Dr. Andrés Benatti will present their insights and clinical experience in the management of Dry Eye.

Where:📍 Booth C2.090 at 43rd The European Society of Cataract and Refractive Surgeons (ESCRS)

Check out our program and save the dates 👇

A new achievement!We are proud to announce that we have been selected, among numerous companies, as one of the three fin...
26/08/2025

A new achievement!

We are proud to announce that we have been selected, among numerous companies, as one of the three finalists at the ESCRS Innovation Day of The European Society of Cataract and Refractive Surgeons (ESCRS) with our QMR technology and latest development.

ESCRS iNovation® Day is a truly unique meeting. It brings together doctors, corporate executives and pioneering companies, highlighting future cutting-edge technologies and solutions for the most urgent clinical needs and barriers in the field of ophthalmology.

This achievement marks an important recognition of the wide-ranging applications of QMR and its role in redefining the future of ocular disease treatment.

👉 For more information: https://lnkd.in/gN4NjfVd

🇩🇰Save the dates!Don't miss the insight speeches from two renowned international experts, sharing their clinical experie...
22/08/2025

🇩🇰Save the dates!

Don't miss the insight speeches from two renowned international experts, sharing their clinical experiences with Rexon-Eye.

📍 booth C2.090, The European Society of Cataract and Refractive Surgeons (ESCRS) Congress, Copenhagen

📅 13 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿:
15:00 – Dr. Giovanni Roberto Tedesco

📅 14 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿:
15:00 – Dr. Andres Benatti


Indirizzo

Sandrigo

Orario di apertura

Lunedì 09:00 - 18:00
Martedì 09:00 - 18:00
Mercoledì 09:00 - 18:00
Giovedì 09:00 - 18:00
Venerdì 09:00 - 18:00

Notifiche

Lasciando la tua email puoi essere il primo a sapere quando Resono Ophthalmic Srl pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.

Contatta Lo Studio

Invia un messaggio a Resono Ophthalmic Srl:

Condividi

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

REinvent Dry Eye treatment

The company RESONO OPHTHALMIC Srl is a young italian company founded in 2014 whose main activities are focused on the development and marketing of highly innovative therapeutic devices with application in the various scopes of ophthalmology.

The key feature of these devices is the use of Quantum Molecular Resonance (QMR), a patented technique that stimulates natural cellular and tissue regeneration through low-frequency high-frequency electric fields. The first clinical application concerns the dry eye syndrome (DES) with the REXON-EYE instrument (Italian and European patents, the US being registered), a medical device that has already obtained the CE mark.

Clinical trials in Italy and abroad, already completed or in progress, have clearly shown that Rexon-Eye is a safe and effective treatment option to improve subjective and objective symptoms in DES. The benefits of QMR in stimulating natural cell and tissue regeneration are currently being studied for potential application to other eye conditions, paving the way for the development of a family of ophthalmic therapeutic tools based on the QMR.